<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title></title>
	<atom:link href="http://mbiodx.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://mbiodx.com</link>
	<description></description>
	<lastBuildDate>Fri, 03 May 2013 00:07:36 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.1</generator>
		<item>
		<title>PRESS RELEASE:MBio Diagnostics and FIND Complete Phase I of TB Serology Program</title>
		<link>http://mbiodx.com/press-releasembio-diagnostics-and-find-complete-phase-i-of-tb-serology-program/press-releasembio-diagnostics-and-find-complete-phase-i-of-tb-serology-program/</link>
		<comments>http://mbiodx.com/press-releasembio-diagnostics-and-find-complete-phase-i-of-tb-serology-program/press-releasembio-diagnostics-and-find-complete-phase-i-of-tb-serology-program/#comments</comments>
		<pubDate>Mon, 22 Apr 2013 17:15:55 +0000</pubDate>
		<dc:creator>MBioEdit</dc:creator>
				<category><![CDATA[Press Release]]></category>

		<guid isPermaLink="false">http://mbiodx.com/?p=642</guid>
		<description><![CDATA[April 22, 2013]]></description>
		<wfw:commentRss>http://mbiodx.com/press-releasembio-diagnostics-and-find-complete-phase-i-of-tb-serology-program/press-releasembio-diagnostics-and-find-complete-phase-i-of-tb-serology-program/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PRESS RELEASE:MBio Diagnostics, Inc. Announces Sue Sutton-Jones joins as VP of Regulatory Affairs and Quality Assurance</title>
		<link>http://mbiodx.com/press-releasembio-diagnostics-inc-announces-sue-sutton-jones-joins-as-vp-of-regulatory-affairs-and-quality-assurance/press-releasembio-diagnostics-inc-announces-sue-sutton-jones-joins-as-vp-of-regulatory-affairs-and-quality-assurance/</link>
		<comments>http://mbiodx.com/press-releasembio-diagnostics-inc-announces-sue-sutton-jones-joins-as-vp-of-regulatory-affairs-and-quality-assurance/press-releasembio-diagnostics-inc-announces-sue-sutton-jones-joins-as-vp-of-regulatory-affairs-and-quality-assurance/#comments</comments>
		<pubDate>Tue, 09 Apr 2013 17:05:39 +0000</pubDate>
		<dc:creator>MBioEdit</dc:creator>
				<category><![CDATA[Press Release]]></category>

		<guid isPermaLink="false">http://mbiodx.com/?p=632</guid>
		<description><![CDATA[April 9, 2013 Download PDF Boulder, CO, April 9, 2013 – MBio Diagnostics, Inc. announced today that it has expanded its leadership team with the addition of Sue Sutton-Jones as Vice President of Regulatory Affairs and Quality Assurance. Ms. Sutton-Jones comes to MBio from ConMed Livatec, a global leader in the fields of arthroscopy, endoscopic [...]]]></description>
		<wfw:commentRss>http://mbiodx.com/press-releasembio-diagnostics-inc-announces-sue-sutton-jones-joins-as-vp-of-regulatory-affairs-and-quality-assurance/press-releasembio-diagnostics-inc-announces-sue-sutton-jones-joins-as-vp-of-regulatory-affairs-and-quality-assurance/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PRESS RELEASE: MBio Diagnostics, Inc. will present at Biotech Showcase in San Francisco, Monday January 7, 2013</title>
		<link>http://mbiodx.com/press-release-mbio-diagnostics-inc-will-present-at-biotech-showcase-in-san-francisco-monday-january-7-2013/press-release-mbio-diagnostics-inc-will-present-at-biotech-showcase-in-san-francisco-monday-january-7-2013/</link>
		<comments>http://mbiodx.com/press-release-mbio-diagnostics-inc-will-present-at-biotech-showcase-in-san-francisco-monday-january-7-2013/press-release-mbio-diagnostics-inc-will-present-at-biotech-showcase-in-san-francisco-monday-january-7-2013/#comments</comments>
		<pubDate>Thu, 03 Jan 2013 21:58:56 +0000</pubDate>
		<dc:creator>MBioEdit</dc:creator>
				<category><![CDATA[Press Release]]></category>

		<guid isPermaLink="false">http://mbiodx.com/?p=589</guid>
		<description><![CDATA[January 3, 2013 Download PDF Boulder, CO, January 3, 2013– MBio Diagnostics, Inc., a diagnostics company focused on enabling better healthcare decisions through immediate multi-disease diagnostics, today announced that Michael J. Lochhead, Ph.D., Vice President of MBio Diagnostics, will present a company overview at the Biotech Showcase, on Monday, January 7 at 2:30 p.m. PST [...]]]></description>
		<wfw:commentRss>http://mbiodx.com/press-release-mbio-diagnostics-inc-will-present-at-biotech-showcase-in-san-francisco-monday-january-7-2013/press-release-mbio-diagnostics-inc-will-present-at-biotech-showcase-in-san-francisco-monday-january-7-2013/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>VIEWS:  MBio applauds Hillary Clintons&#8217; blueprint for an AIDS Free generation</title>
		<link>http://mbiodx.com/views-mbio-appauds-hillary-clintons-blueprint-for-an-aids-free-generation/views-mbio-appauds-hillary-clintons-blueprint-for-an-aids-free-generation/</link>
		<comments>http://mbiodx.com/views-mbio-appauds-hillary-clintons-blueprint-for-an-aids-free-generation/views-mbio-appauds-hillary-clintons-blueprint-for-an-aids-free-generation/#comments</comments>
		<pubDate>Tue, 04 Dec 2012 02:44:27 +0000</pubDate>
		<dc:creator>MBioEdit</dc:creator>
				<category><![CDATA[Views]]></category>

		<guid isPermaLink="false">http://mbiodx.com/?p=564</guid>
		<description><![CDATA[December 3, 2012 Read article here. MBio applauds the &#8220;blueprint&#8221; that US Secretary of State Hilary Clinton has put forth, showing how an AIDS free generation can be achieved. We at MBio look to support the roll-out of life-saving medicines throughout the world, and we agree with the growing consensus that increased use of anti-retroviral [...]]]></description>
		<wfw:commentRss>http://mbiodx.com/views-mbio-appauds-hillary-clintons-blueprint-for-an-aids-free-generation/views-mbio-appauds-hillary-clintons-blueprint-for-an-aids-free-generation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>VIEWS:  Dr. Chris Myatt Participates in Colorado Medical Device Symposium</title>
		<link>http://mbiodx.com/views-dr-chris-myatt-participates-in-colorado-medical-device-symposium/views-dr-chris-myatt-participates-in-colorado-medical-device-symposium/</link>
		<comments>http://mbiodx.com/views-dr-chris-myatt-participates-in-colorado-medical-device-symposium/views-dr-chris-myatt-participates-in-colorado-medical-device-symposium/#comments</comments>
		<pubDate>Thu, 15 Nov 2012 21:27:38 +0000</pubDate>
		<dc:creator>MBioEdit</dc:creator>
				<category><![CDATA[Views]]></category>

		<guid isPermaLink="false">http://mbiodx.com/?p=541</guid>
		<description><![CDATA[November 15, 2012 Yesterday, Chris Myatt, CEO &#038; Founder of MBio, participated in the Colorado Bioscience Association’s Medical Device Symposium, focusing on the current challenges faced by medical device manufacturers. At a forum of nearly 100 attendees, Dr. Myatt shared how MBio’s current strategy has evolved to address the economic, regulatory and commercial hurdles faced [...]]]></description>
		<wfw:commentRss>http://mbiodx.com/views-dr-chris-myatt-participates-in-colorado-medical-device-symposium/views-dr-chris-myatt-participates-in-colorado-medical-device-symposium/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NEWS: MBio Diagnostics, Inc. Announces that Michael Seely has joined as its Chief Commercial Officer</title>
		<link>http://mbiodx.com/news-mbio-diagnostics-inc-announces-that-michael-seely-has-joined-as-its-chief-commercialization-officer/news-mbio-diagnostics-inc-announces-that-michael-seely-has-joined-as-its-chief-commercialization-officer/</link>
		<comments>http://mbiodx.com/news-mbio-diagnostics-inc-announces-that-michael-seely-has-joined-as-its-chief-commercialization-officer/news-mbio-diagnostics-inc-announces-that-michael-seely-has-joined-as-its-chief-commercialization-officer/#comments</comments>
		<pubDate>Thu, 08 Nov 2012 16:47:21 +0000</pubDate>
		<dc:creator>MBioWeb</dc:creator>
				<category><![CDATA[Press Release]]></category>

		<guid isPermaLink="false">http://mbiodx.com/?p=527</guid>
		<description><![CDATA[November 8, 2012 PR 2012-1101 Michael Seely joins MBio MBio Diagnostics, Inc. announced today that it has expanded its executive leadership team with the addition of Michael Seely as Chief Commercial Officer. Mr. Seely brings 20 years experience building high performance international organizations in the medical device sector having worked most recently for Gambro/CaridianBCT in [...]]]></description>
		<wfw:commentRss>http://mbiodx.com/news-mbio-diagnostics-inc-announces-that-michael-seely-has-joined-as-its-chief-commercialization-officer/news-mbio-diagnostics-inc-announces-that-michael-seely-has-joined-as-its-chief-commercialization-officer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>EVENTS: MBio Diagnostics, Inc. to Participate in African Society for Laboratory Medicine Meeting in Cape Town, South Africa, December 1-7, 2012</title>
		<link>http://mbiodx.com/events-mbio-diagnostics-inc-to-participate-in-african-society-for-laboratory-medicine-meeting-in-cape-town-south-africa-december-1-7-2012/events-mbio-diagnostics-inc-to-participate-in-african-society-for-laboratory-medicine-meeting-in-cape-town-south-africa-december-1-7-2012/</link>
		<comments>http://mbiodx.com/events-mbio-diagnostics-inc-to-participate-in-african-society-for-laboratory-medicine-meeting-in-cape-town-south-africa-december-1-7-2012/events-mbio-diagnostics-inc-to-participate-in-african-society-for-laboratory-medicine-meeting-in-cape-town-south-africa-december-1-7-2012/#comments</comments>
		<pubDate>Fri, 26 Oct 2012 13:42:11 +0000</pubDate>
		<dc:creator>MBioEdit</dc:creator>
				<category><![CDATA[Events]]></category>

		<guid isPermaLink="false">http://mbiodx.com/?p=514</guid>
		<description><![CDATA[October 26, 2012 The African Society of Laboratory Medicine is a Pan-African professional body that works with countries to advocate for the critical role and needs of laboratory medicine. Headquartered in Addis Ababa, Ethiopia, the ASLM is organizing their first international conference in South Africa, bringing together professionals from the field of laboratory medicine, as [...]]]></description>
		<wfw:commentRss>http://mbiodx.com/events-mbio-diagnostics-inc-to-participate-in-african-society-for-laboratory-medicine-meeting-in-cape-town-south-africa-december-1-7-2012/events-mbio-diagnostics-inc-to-participate-in-african-society-for-laboratory-medicine-meeting-in-cape-town-south-africa-december-1-7-2012/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NEWS: MBio Congratulates Dr. David Wineland on Winning the Nobel Prize</title>
		<link>http://mbiodx.com/news-mbio-congratulates-dr-david-wineland-on-winning-the-nobel-prize/news-mbio-congratulates-dr-david-wineland-on-winning-the-nobel-prize/</link>
		<comments>http://mbiodx.com/news-mbio-congratulates-dr-david-wineland-on-winning-the-nobel-prize/news-mbio-congratulates-dr-david-wineland-on-winning-the-nobel-prize/#comments</comments>
		<pubDate>Tue, 09 Oct 2012 22:24:20 +0000</pubDate>
		<dc:creator>MBioEdit</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://mbiodx.com/?p=485</guid>
		<description><![CDATA[October 9, 2012 Read news release here. This week, David Wineland of the National Institute of Standards and Technology and the University of Colorado at Boulder, was awarded the 2012 Nobel Prize in Physics, along with Professor Serge Haroche of the Collège de France and Ecole Normale Supérieure. Dr. Wineland acted as an advisor at [...]]]></description>
		<wfw:commentRss>http://mbiodx.com/news-mbio-congratulates-dr-david-wineland-on-winning-the-nobel-prize/news-mbio-congratulates-dr-david-wineland-on-winning-the-nobel-prize/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PRESS RELEASE: MBio Diagnostics, Inc. Initiates Clinical Evaluation in Mozambique</title>
		<link>http://mbiodx.com/clinical-evaluation-in-mozambique/clinical-evaluation-in-mozambique/</link>
		<comments>http://mbiodx.com/clinical-evaluation-in-mozambique/clinical-evaluation-in-mozambique/#comments</comments>
		<pubDate>Sun, 01 Jul 2012 19:52:25 +0000</pubDate>
		<dc:creator>MBioWeb</dc:creator>
				<category><![CDATA[Press Release]]></category>

		<guid isPermaLink="false">http://mbiodx.com/wp/?p=118</guid>
		<description><![CDATA[July 1, 2012 Download PDF Boulder, CO, July 1, 2012 – MBio Diagnostics, Inc. announced that it has initiated a pre-market, clinical laboratory evaluation of its point-of-care diagnostic platforms in Mozambique. MBio is working with collaborators at the University of California, San Diego and the Universidade Eduardo Mondlane in Maputo, Mozambique. MBio Diagnostics is developing [...]]]></description>
		<wfw:commentRss>http://mbiodx.com/clinical-evaluation-in-mozambique/clinical-evaluation-in-mozambique/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>VIEWS: “India in Race to Contain Untreatable Tuberculosis.”  Highlights the importance of rapid and early diagnosis, as well as the need for tests to monitor the progress of therapy.</title>
		<link>http://mbiodx.com/india-in-race-to-contain-untreatable-tuberculosis-highlights-the-importance-of-rapid-and-early-diagnosis-as-well-as-the-need-for-tests-to-monitor-the-progress-of-therapy/india-in-race-to-contain-untreatable-tuberculosis-highlights-the-importance-of-rapid-and-early-diagnosis-as-well-as-the-need-for-tests-to-monitor-the-progress-of-therapy/</link>
		<comments>http://mbiodx.com/india-in-race-to-contain-untreatable-tuberculosis-highlights-the-importance-of-rapid-and-early-diagnosis-as-well-as-the-need-for-tests-to-monitor-the-progress-of-therapy/india-in-race-to-contain-untreatable-tuberculosis-highlights-the-importance-of-rapid-and-early-diagnosis-as-well-as-the-need-for-tests-to-monitor-the-progress-of-therapy/#comments</comments>
		<pubDate>Tue, 19 Jun 2012 19:53:01 +0000</pubDate>
		<dc:creator>MBioWeb</dc:creator>
				<category><![CDATA[Views]]></category>

		<guid isPermaLink="false">http://mbiodx.com/wp/?p=315</guid>
		<description><![CDATA[June 19, 2012 Read article here.]]></description>
		<wfw:commentRss>http://mbiodx.com/india-in-race-to-contain-untreatable-tuberculosis-highlights-the-importance-of-rapid-and-early-diagnosis-as-well-as-the-need-for-tests-to-monitor-the-progress-of-therapy/india-in-race-to-contain-untreatable-tuberculosis-highlights-the-importance-of-rapid-and-early-diagnosis-as-well-as-the-need-for-tests-to-monitor-the-progress-of-therapy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
